Delivery Order SPE2DR25D3103-SPE2DR26F9X55
- Not listed
- The Defense Logistics Agency awarded a $14,053.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5ML) on May 30, 2025, with an ultimate completion date of June 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded without set-aside designation and will be...
- The Defense Logistics Agency awarded a $21,373.10 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for HYPERRAB 300 Unit/ML Vial 5ML, with completion expected by October 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $42,979.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vials (5 mL) with an ultimate completion date of October 17, 2025. This is a non-set-aside, competitively awarded contract with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 21, 2025, for the supply of HYPERRAB 300 Unit/ML Vial pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $3,465.10 with an ultimate completion date of October 10, 2025, and was awarded without set-aside designations through competitive procedures. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials, with a ceiling value of $4,158.12. This is a firm fixed price delivery order with no set-aside designation, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger contract vehicle and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,270.10 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4566039591 HYPERRAB 300 UNIT/ML VIAL 5ML, with a period of performance through October 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which provides a...
- The Defense Logistics Agency awarded a $1,732.55 delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials (5mL) with a ceiling value of $17,337.40 under a firm fixed price contract type. The award was made on November 20, 2025, with an ultimate completion date of December 12, 2025. This delivery order is non-set-aside and competitively awarded, reflecting AmerisourceBergen's capability to meet federal procurement requirements. The place of performance is the company's corporate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,002.16 firm fixed-price delivery order is for 4,564,997,687 units of the HYPERRAB 300 UNIT/ML VIAL 5ML product. The contract has an ultimate completion date of July 17, 2024 and was awarded on June 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $9,391.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, to Conshohocken, Pennsylvania by March 12, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9X55Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,263.36 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL Vials on January 14, 2026, with an ultimate completion date of February 5, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to the Place of Performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, continues to fulfill critical medical supply needs for the federal government through this delivery order and its extensive portfolio of federal contracts. The company operates as a subsidiary of Cencora, Inc., and has demonstrated sustained capability to meet DLA procurement requirements through competitive award processes. The IDC vehicle enables efficient delivery of a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/13/26 |